Stocktoria

Polyrizon Ltd. PLRZ

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2024-10-29

Polyrizon Ltd. statistics & valuation

Market cap$23.9M
P / B1.1×
Return on equity-15.9%
Return on capital-29.8%
Graham number +290.3%$37.94

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($37.94); a green figure means the price is below it.

Profitability & efficiency

Gross margin (%)
202320242025
Operating margin (%)
202320242025
Return on equity (%)
-29.20% -15.90% 202320242025
Shares outstanding
2.6M 4.2M 1.6M 202320242025
Net debt ($)
202320242025
Share buybacks ($)
202320242025
Return on assets (%)
-107.30% -27.90% -15.60% 202320242025
Free cash flow margin (%)
202320242025
Debt / equity (×)
202320242025
EPS ($)
$494.40 $805.20 $4.90 202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023
Return on assets-15.6%-27.9%-107.3%
Return on equity-15.9%-29.2%314.1%
Current ratio29.0310.160.11

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.